|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2005-05-10 Sale |
2005-05-10 6:17 pm | RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (VP Intel. Prop.& Gen.Counsel) | 15,000 | $19.71 | $295,650 | 4,385 (Direct) | View |
| 2005-03-30 Purchase |
2005-03-30 5:41 pm | RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (VP Intel. Prop.& Gen.Counsel) | 1,000 | $15.99 | $15,990 | 4,385 (Direct) |
View |
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount | Shares Ownership |
Filing |
| 2005-05-10 Exercise | 2005-05-10 6:17 pm |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (VP Intel. Prop.& Gen.Counsel) | 15,000 | $9.2 | $138,000 | 19,385 (Direct) | View |
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded | Conversion Price |
Shares Ownership | Filing |
| 2008-01-31 Option Award | 2008-02-04 7:43 pm |
2008-02-01 2018-01-31 | RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (SVP, Gen. Counsel, Corp. Sec.) | 90,000 | $26.45 | 90,000 (Direct) | View |
| 2007-01-31 Option Award | 2007-02-01 7:33 pm | 2007-02-01 2017-01-31 | RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (SVP, Gen. Counsel, Corp. Sec.) | 103,788 | $11.73 | 103,788 (Direct) | View |
| 2006-08-07 Option Award | 2006-08-08 9:07 pm | 2006-08-07 2016-08-07 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (VP Intel. Prop.& Gen.Counsel) | 16,249 | $9.56 | 16,249 (Direct) |
View |
| 2006-01-25 Option Award | 2006-01-27 5:37 pm | 2006-02-01 2016-01-25 | RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (VP Intel. Prop.& Gen.Counsel) | 45,000 | $7.4 | 45,000 (Direct) |
View |
| 2005-10-04 Option Award | 2005-10-06 5:51 pm | 2005-11-04 2015-10-04 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (VP Intel. Prop.& Gen.Counsel) | 80,000 | $24.56 | 80,000 (Direct) |
View |
| 2005-05-10 Exercise |
2005-05-10 6:17 pm | 2004-01-28 2006-08-04 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (VP Intel. Prop.& Gen.Counsel) | 15,000 | $9.2 | 16,249 (Direct) |
View |
| 2005-01-20 Option Award |
2005-02-01 3:33 pm |
2005-02-01 2015-01-20 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (VP Intel. Prop.& Gen.Counsel) | 38,751 | $22.17 | 38,751 (Direct) |
View |
| 2004-06-03 Option Award |
2004-06-04 7:47 pm |
2004-07-03 2014-06-03 | RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (VP Intel. Prop.& Gen.Counsel) | 45,000 | $17.66 | 45,000 (Direct) |
View |
| 2003-07-28 Option Sale | 2003-07-30 3:00 pm | N/A 2010-09-21 | RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (Gen. Counsel, VP I.P.) | 0 | $81 | 17,360 (Direct) |
View |
| 2003-07-28 Option Sale |
2003-07-30 3:00 pm | N/A 2011-10-18 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (Gen. Counsel, VP I.P.) | 0 | $51.93 | 13,888 (Direct) | View |
| 2003-07-28 Option Sale |
2003-07-30 3:00 pm | N/A 2012-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (Gen. Counsel, VP I.P.) | 0 | $41.58 | 11,111 (Direct) | View |
| 2003-07-28 Option Sale | 2003-07-30 3:00 pm |
N/A 2013-01-21 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (Gen. Counsel, VP I.P.) | 0 | $9.09 | 0 (Direct) | View |
| 2003-07-28 Option Award |
2003-07-30 3:00 pm | N/A 2006-07-28 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY (Gen. Counsel, VP I.P.) | 0 | $9.2 | 31,249 (Direct) |
View |
|
© 2005-2008 SecForm4.Com All rights reserved. Archives: 2008 2007 2006 2005 2004 2003 Fri, 05 Dec 2008 04:19:40 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |